![Leslie Chong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leslie Chong
Chief Executive Officer at
IMUGENE LIMITED
Net worth: 212 153 $ as of 2026-06-29
Profile
Leslie Chong is currently the Chief Executive Officer, MD & Director at Imugene Ltd. Prior to this, Ms. Chong held positions as Director at Cure Brain Cancer Foundation from 2020 to 2023, Independent Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) from 2020 to 2023, and had roles in the Clinical Operation Department at Pharmaceutical Product Development LLC, Exelixis, Inc., and GSK Plc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMUGENE LTD 0.64% | 2025-08-11 | 2,662,899 ( 0.64% ) | 212 153 $ | 2026-06-29 |
Leslie Chong active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Chief Executive Officer | 2016-10-31 |
Former positions of Leslie Chong
| Companies | Position | End |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 2023-07-11 |
Cure Brain Cancer Foundation
 Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as organization for brain cancer research, awareness and advocacy in Australia | Director/Board Member | 2023-04-10 |
| GSK PLC | Corporate Officer/Principal | 2005-12-31 |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Cure Brain Cancer Foundation
Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as organization for brain cancer research, awareness and advocacy in Australia | Commercial Services |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
- Stock Market
- Insiders
- Leslie Chong
